MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Psychosis"

  • 2017 International Congress

    Domain-Specific Cognitive Impairment in Non-Demented Parkinson’s Disease Psychosis

    J. Hinkle, K. Perepezko, C. Bakker, T. Dawson, V. Johnson, Z. Mari, C. Marvel, K. Mills, A. Pantelyat, O. Pletnikova, L. Rosenthal, M. Shepard, D. Stevens, J. Troncoso, J. Wang, G. Pontone (Baltimore, MD, USA)

    Objective: Our objective was to determine whether psychosis in non-demented Parkinson’s disease (PD) patients is associated with domain-specific cognitive impairment on the Mini-Mental State Exam…
  • 2017 International Congress

    Treatment of Psychosis in Parkinson’s Disease: Evidence-Based Recommendations Versus Actual Clinical Practice

    L.G. Chan, A. Kong, L. Tan (Singapore, Singapore)

    Objective: To examine if actual clinical practice of antipsychotic use in Parkinson's Disease patients are consistent with published evidence-based reviews of treatment recommendations and discuss…
  • 2017 International Congress

    Use of pimavanserin in patients with Parkinson’s disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment

    D. Weintraub, J. Norton, D. Fredericks, B. Coate, C. Andersson, C. Ballard (Philadelphia, PA, USA)

    Objective: A planned subgroup analysis of a phase 3 study was performed to evaluate the efficacy and safety of pimavanserin (PIM) in Parkinson’s disease psychosis…
  • 2017 International Congress

    A Phase 2 Study of Nelotanserin, a Novel 5HT2A Receptor Inverse Agonist, in Dementia with Lewy Bodies and Parkinson’s Disease Dementia Subjects Experiencing Visual Hallucinations

    S. Ramaswamy, W. Wen, G. Ramaswamy, L. Friedhoff (New York, NY, USA)

    Objective: To evaluate the safety and efficacy of nelotanserin in Lewy body dementia subjects experiencing visual hallucinations. Background: Nelotanserin is a selective 5HT2A receptor inverse…
  • 2017 International Congress

    Key clinical milestones 15 years and onwards after DBS-STN surgery – a retrospective analysis of patients that underwent surgery between 1993 and 2001

    R. Constantinescu, B. Eriksson, Y. Jansson, B. Johnels, B. Holmberg, T. Gudmundsdottir, A. Renck, P. Berglund, F. Bergquist (Göteborg, Sweden)

    Objective: In this paper we investigated patients with advanced Parkinson's disease (PD) operated at our center with subthalamic nucleus deep brain stimulation (STN-DBS) for at…
  • 2017 International Congress

    Aberrant resting state functional brain networks in patients with Parkinson’s disease and visual hallucinations

    A. Lenka, R. Panda, L. George, S. Hegde, S. Arumugham, J. Saini, R. Bharath, P. Pal (Bangalore, India)

    Objective:  To explore the neural correlates of Visual Hallucinations (VH) in patients with Parkinson’s disease (PD). Background: Psychosis is one of the commonly observed non-motor…
  • 2017 International Congress

    Postoperative delirium after deep brain stimulation surgery for Parkinson’s disease

    F. Sasaki, G. Oyama, M. Ito, S. Sekimoto, R. Nakamura, T. Jo, Y. Simo, A. Umemura, N. Hattori (Tokyo, Japan)

    Objective: To investigate the potential predictive factors of postoperative delirium after deep brain stimulation surgery for Parkinson’s disease (PD). Background: Subthalamic nucleus deep brain stimulation…
  • 2016 International Congress

    Predictors of transfer to community hospital or nursing home after discharge of inpatients with Parkinson’s disease: A Japanese single center retrospective study

    K. Ikeda, K. Takahashi, T. Furuya, A. Miyake, T. Mitsufuji, A. Tanaka, Y. Ito, T. Sasaki, Y. Nakazato, N. Araki, T. Yamamoto (Saitama-ken, Japan)

    Objective: To investigate the reasons for hospital admissions for patients with Parkinson's disease (PD) and to determine the predictors of transfer to community hospital or…
  • 2016 International Congress

    Genetic risk factors of dementia and psychosis in Parkinson’s disease

    T. Oeda, A. Umemura, Y. Mori, S. Tomita, M. Kohsaka, K. Park, K. Inoue, H. Fujimura, H. Hasegawa, H. Sugiyama, H. Sawada (Kyoto, Japan)

    Objective: We investigated the impacts of apolipoprotein E (APOE) genotype and glucocerebrosidase gene (GBA) heterozygote mutations on dementia or psychosis in Parkinson's disease (PD). Background:…
  • 2016 International Congress

    Psychosis in Huntington’s disease

    J. Perez-Perez, S. Martinez-Horta, M. Carceller, J. Pagonabarraga, A. Horta, R. Fernandez-Bobabilla, J. Kulisevsky (Barcelona, Spain)

    Objective: To describe the characteristics and phenomenology of psychotic symptoms in a Spanish cohort of HD patients. Background: Neuropsychiatric features are characteristic symptoms in Huntington's…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley